Anger over uncertain future of Whitehawk GP surgery
Residents have expressed concern that a community-run, not-for-profit GP surgery in Brighton could be replaced with a private provider. Wellsbourne Healthcare Community Interest Company (CIC) currently runs the surgery in Whitehawk, but it could be taken over by Leeds-based One Medical Group after NHS Sussex started procuring a new contract. Patient Liz Mason told BBC Radio Sussex it would be an "absolute travesty" if the GP surgery that had "done so much for the community" was lost. NHS Sussex said it was aware of the concern being raised and would respond as soon as it could.
It added that it was unable to comment further as the procurement process had begun. One Medical Group has been approached for comment.
'Why risk it?'
Lacey, another patient, said it was vital that Whitehawk - which she said was "let down quite a lot" as one of the most deprived areas in the city - had a GP they could trust. "Things have been running so well for so long - why risk it [the change]?" she told BBC Radio Sussex. "This service is amazing." Wellsbourne Healthcare CIC took over the GP surgery several years ago after it was previously failing. NHS Sussex said the possible change was needed because the current contract to run the GP service for some 8,300 people had ended.
Hundreds stuck in Sussex hospitals, BBC told
They detailed that national regulations mean the procurement process has to be open, allowing all parties to submit bids that will be fully considered and evaluated. The healthcare provider added the new contract was designed to meet the current and future needs of the local population.Sarah Webb, business manager at Wellsbourne Healthcare CIC, urged NHS Sussex to talk to the people of Whitehawk."There is still time for them to be heard," she added. "Listen to residents and the community here."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
32 minutes ago
- Daily Mail
Awkward! How the new chairman of Reform UK called party leader Nigel Farage 'an idiot' and branded his comments about HIV-infected migrants using the NHS 'prejudiced'
Reform UK's new chairman once called leader Nigel Farage an 'idiot', it emerged last night. Dr David Bull, who was unveiled as Zia Yusuf's replacement, also branded as 'prejudiced' comments that Mr Farage had made about HIV-infected migrants using the NHS. The remarks surfaced just hours after Dr Bull gave his maiden speech as chairman and threatened to overshadow his appointment, while at a Press conference unveiling the new chairman, Mr Farage unexpectedly ruled out putting the return of the death penalty on Reform's manifesto at the next general election. Dr Bull's comments, first reported by The Daily Telegraph, were made on social media in 2014. He posted them after Mr Farage, then leader of his previous party UKIP, suggested that HIV-positive immigrants should not be allowed to come to the UK and receive treatment on the NHS. He said it should not be used as a 'global health service', adding: 'I do not think people with life-threatening diseases should be treated by our National Health Service, and that is an absolute essential condition for working out a proper immigration policy.' Sharing an article about Mr Farage's comments, Dr Bull wrote on X/ Twitter: 'Nigel Farage's comments are ill-judged, prejudiced and dangerous. HIV can affect anyone regardless of sex, race and class.' In the post, still visible online, he added: '#idiot #unhelpful.' Dr Bull, 56, is a long-time ally of Mr Farage and has held roles in both Reform and its former iteration, the Brexit Party. He served as an MEP for North West England between 2019 and 2020. Mr Farage said that Dr Bull would bring 'terrific verve, energy, enthusiasm' to his new role. Mr Yusuf plunged the party into turmoil on Thursday after announcing his shock resignation on social media, giving Mr Farage only ten minutes' notice. He said he was quitting after attacking one of his own MPs, Sarah Pochin, for calling for a burka ban during Prime Minister's Questions. But just 48 hours after leaving, he said he was returning to the party. The 38-year-old businessman said his resignation had been 'born of exhaustion' after working for the party for 11 months 'without a day off'. He will now lead Reform's Elon Musk-inspired Doge unit, which the party says will root out wasteful spending in the ten councils it controls, starting in Kent. The decision not to include anything in Reform's manifesto about the death penalty will likely disappoint millions of its voters. A poll by the think-tank More In Common in January found nearly eight in ten of its backers support it 'for certain crimes'. Mr Farage said 'nothing on the death penalty will be part of [Reform] party policy' and that 'personally I don't think I could ever support it'. He said he was opposed because of hundreds of 'quite serious miscarriages of justice' having emerged since the 70s, adding that he believed it will become a big national issue because of polling suggesting younger generations are increasingly in favour. It may lead to suspicions that Mr Farage is trying to make Reform UK appear less Right-wing and controversial as it increasingly tries to target Labour voters. It also emerged that Reform lost nearly 3,500 members in the past week amid the Yusuf fiasco.
The Sun
38 minutes ago
- The Sun
Major boost to NHS as robotic surgery will slash stubbornly high waiting lists – but it'll take a decade
ROBOTIC surgery will slash waiting lists in a decade, the head of the NHS will say today. NHS England estimates robotic systems will be used in half a million operations a year by 2035, compared with 70,000 last year. That will include nine out of ten keyhole ops in the gut and pelvis, and increasing numbers of emergency surgeries. Health service boss Sir Jim Mackey will say at an NHS conference today: 'We have pledged to return to shorter elective waiting times by 2029 and we are using every tool at our disposal. 'Robotic surgery will play a huge part in this. 'Not only does it speed up the number of procedures the NHS can do, but it also means better outcomes, faster recoveries and shorter hospital stays.' Waiting lists in England are stubbornly high at 7.4million. The total increased in March as demand soared at a time of staff and cash shortages. Robot-assisted surgery uses super-precise mechanical arms that are electronically controlled by a surgeon and do internal operating work through tiny incisions on the body. They can be used for many common operations including hernia repairs, organ removals, hip and knee replacements and cancer treatment. Patients often have less blood loss, less scarring and need less anaesthetic, helping them recover faster. More than 140 robots are already in use across the UK. The NHS spending watchdog Nice recently approved 11 machines for use in England in the hope it will end a postcode lottery in their use.
The Guardian
41 minutes ago
- The Guardian
Public health bodies urged to launch period tracking apps to protect data
Public health bodies should launch alternatives to commercial period tracker apps, experts have said, as a report warns women's personal data is at risk of being harvested by private companies. Smartphone apps that track menstrual cycles are a 'goldmine' for consumer profiling, collecting information on everything from exercise, diet and medication to sexual preferences, hormone levels and contraception use, according to the research by the University of Cambridge. And the financial worth of this data is 'vastly underestimated' by users who supply profit-driven companies with highly intimate details in a market lacking regulation, the report says. In the wrong hands, cycle tracking app (CTA) data could result in risks to job prospects, workplace monitoring, health insurance discrimination and cyberstalking, and even limit access to abortion, the research suggests. The authors call for better governance of the booming femtech industry to protect users when their data is sold at scale, arguing that apps must provide clear consent options rather than all-or-nothing data collection, and urge public health bodies to launch alternatives to commercial CTAs. 'Menstrual cycle tracking apps are presented as empowering women and addressing the gender health gap,' said the report's lead author, Dr Stefanie Felsberger, of Cambridge's Minderoo Centre for Technology and Democracy. 'Yet the business model behind their services rests on commercial use, selling user data and insights to third parties for profit. 'There are real and frightening privacy and safety risks to women as a result of the commodification of the data collected by cycle tracking app companies.' Most cycle tracking apps are targeted at women aiming to get pregnant, so the download data alone is of huge commercial value, according to the report. Along with homebuying, no other life event is linked to such dramatic shifts in consumer behaviour. Data on pregnancy is believed to be more than 200 times more valuable than data on age, gender or location for targeted advertising. The report says period tracking could also be used to target women at different points in their cycle. The three most popular apps had estimated global download figures of a quarter of a billion in 2024. The femtech market – digital products focused on women's health and wellbeing – will be worth more than $60bn (£44bn) by 2027, the report says. With such intense demand for period tracking, the authors called on public health bodies including the NHS in the UK to develop their own transparent and trustworthy apps to rival those from private companies, with apps allowing permission for data to be used in medical research. 'The UK is ideally positioned to solve the question of access to menstrual data for researchers, as well as privacy and data commodification concerns, by developing an NHS app to track menstrual cycles,' said Felsberger, who added that the reproductive health provider Planned Parenthood in the US already had its own app but the UK lacked an equivalent. 'Apps that are situated within public healthcare systems, and not driven primarily by profit, will mitigate privacy violations, provide much-needed data on reproductive health, and give people more agency over how their menstrual data is used.' Prof Gina Neff, the executive director of the Minderoo Centre, said: 'The use of cycle tracking apps is at an all-time high. Women deserve better than to have their menstrual tracking data treated as consumer data.' In the UK and EU, period tracking data is considered 'special category', as with that on genetics or ethnicity, and has more legal safeguarding. In the US, data on menstrual cycles has been collected by officials in an attempt to undermine abortion access, the report says.
